Loading...
Loading...
India's amphotericin imports from TAIWAN total $11.9M across 3 shipments from 2 foreign suppliers. TTY BIOPHARM COMPANY LIMITED leads with $11.9M in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include EUGIA PHARMA SPECIALITIES LIMITED. This corridor reflects India's pharmaceutical import demand for amphotericin — a concentrated sourcing relationship with select suppliers from TAIWAN.

TTY BIOPHARM COMPANY LIMITED is the leading Amphotericin supplier from TAIWAN to India, with import value of $11.9M across 2 shipments. The top 5 suppliers — TTY BIOPHARM COMPANY LIMITED, TAIWAN LIPOSOME COMPANY LTD — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | TTY BIOPHARM COMPANY LIMITED | $11.9M | 2 | 100.0% |
| 2 | TAIWAN LIPOSOME COMPANY LTD | $295 | 1 | 0.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | EUGIA PHARMA SPECIALITIES LIMITED | $11.9M | 2 | 100.0% |
| 2 | ZYDUS HEALTHCARE LIMITED | $295 | 1 | 0.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Amphotericin suppliers from TAIWAN to India include TTY BIOPHARM COMPANY LIMITED, TAIWAN LIPOSOME COMPANY LTD. The leading supplier is TTY BIOPHARM COMPANY LIMITED with import value of $11.9M USD across 2 shipments. India imported Amphotericin worth $11.9M USD from TAIWAN in total across 3 shipments.
India imported Amphotericin worth $11.9M USD from TAIWAN across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Amphotericin sourced from TAIWAN include EUGIA PHARMA SPECIALITIES LIMITED, ZYDUS HEALTHCARE LIMITED. The largest buyer is EUGIA PHARMA SPECIALITIES LIMITED with $11.9M in imports across 2 shipments.
The total value of Amphotericin imports from TAIWAN to India is $11.9M USD, across 3 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
2 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists